| The VALUE national hysterectomy study: description of the patients and their surgery MJA Maresh, MA Metcalfe, K McPherson, C Overton, V Hall, J Hargreaves, ... BJOG: An International Journal of Obstetrics & Gynaecology 109 (3), 302-312, 2002 | 406 | 2002 |
| Severe complications of hysterectomy: the VALUE study K McPherson, MA Metcalfe, A Herbert, M Maresh, A Casbard, ... BJOG: An International Journal of Obstetrics & Gynaecology 111 (7), 688-694, 2004 | 283 | 2004 |
| Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a … RH Jones, A Casbard, M Carucci, C Cox, R Butler, F Alchami, TA Madden, ... The Lancet Oncology 21 (3), 345-357, 2020 | 217 | 2020 |
| Barcode technology: its role in increasing the safety of blood transfusion CL Turner, AC Casbard, MF Murphy Transfusion 43 (9), 1200-1209, 2003 | 206 | 2003 |
| Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion HC Segal, C Briggs, S Kunka, A Casbard, P Harrison, SJ Machin, ... British journal of haematology 128 (4), 520-525, 2005 | 201 | 2005 |
| Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty M Grover, S Talwalkar, A Casbard, H Boralessa, M Contreras, ... Vox sanguinis 90 (2), 105-112, 2006 | 153 | 2006 |
| The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host disease LM Williamson, D Stainsby, H Jones, E Love, CE Chapman, C Navarrete, ... Transfusion 47 (8), 1455-1467, 2007 | 146 | 2007 |
| Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial P Barrett-Lee, A Casbard, J Abraham, K Hood, R Coleman, P Simmonds, ... The Lancet Oncology 15 (1), 114-122, 2014 | 145 | 2014 |
| Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up JIG Strang, AJ Nunn, DA Johnson, A Casbard, DG Gibson, DJ Girling Qjm 97 (8), 525-535, 2004 | 145 | 2004 |
| The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review AC Casbard, LM Williamson, MF Murphy, K Rege, T Johnson Anaesthesia 59 (6), 550-558, 2004 | 119 | 2004 |
| Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer … SJ Howell, A Casbard, M Carucci, K Ingarfield, R Butler, S Morgan, ... The Lancet Oncology 23 (7), 851-864, 2022 | 116 | 2022 |
| End‐to‐end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses A Davies, J Staves, J Kay, A Casbard, MF Murphy Transfusion 46 (3), 352-364, 2006 | 102 | 2006 |
| The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service AW Wells, CA Llewelyn, A Casbard, AJ Johnson, M Amin, S Ballard, ... Transfusion Medicine 19 (6), 315-328, 2009 | 101 | 2009 |
| Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma MA Morgan, WG Lewis, A Casbard, SA Roberts, R Adams, GWB Clark, ... Journal of British Surgery 96 (11), 1300-1307, 2009 | 75 | 2009 |
| HPA‐1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia C Ghevaert, K Campbell, P Stafford, P Metcalfe, A Casbard, GA Smith, ... Transfusion 47 (7), 1296-1305, 2007 | 65 | 2007 |
| Prevention of bedside errors in transfusion medicine (PROBE‐TM) study: a cluster‐randomized, matched‐paired clinical areas trial of a simple intervention to reduce errors in … MF Murphy, AC Casbard, S Ballard, IA Shulman, N Heddle, JP Aubuchon, ... Transfusion 47 (5), 771-780, 2007 | 59 | 2007 |
| Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin‐treated diabetes (MITRE Study) D Cooke, SJ Hurel, A Casbard, L Steed, S Walker, S Meredith, AJ Nunn, ... Diabetic medicine 26 (5), 540-547, 2009 | 52 | 2009 |
| Preoperative transfusion in sickle cell disease: a survey of practice in England J Buck, A Casbard, C Llewelyn, T Johnson, S Davies, L Williamson European journal of haematology 75 (1), 14-21, 2005 | 48 | 2005 |
| Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION … RH Jones, M Carucci, AC Casbard, R Butler, F Alchami, CJ Bale, ... Journal of Clinical Oncology 37 (15_suppl), 1005-1005, 2019 | 47 | 2019 |
| Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic … E Harrop, J Kelly, G Griffiths, A Casbard, A Nelson, ... Trials 17, 1-11, 2016 | 45 | 2016 |
